Molecule Information
General Information of the Molecule (ID: Mol02232)
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Ischemia/reperfusion injury [ICD-11: DB98.B] | [1] | |||
| Resistant Disease | Ischemia/reperfusion injury [ICD-11: DB98.B] | |||
| Resistant Drug | Hydrogen peroxide | |||
| Molecule Alteration | Down-regulation | Expression |
||
| Experimental Note | Discovered Using In-vivo Testing Model | |||
| Cell Pathway Regulation | PPAR-gama/Bcl-2 signaling pathway | Activation | hsa04933 | |
| In Vitro Model | NMVCs | N.A. | N.A. | N.A. |
| In Vivo Model | C57BL/6 mice and neonatal mice model of I/R injury model | Mus musculus | ||
| Experiment for Molecule Alteration |
Knockdown assay; Overexpression assay | |||
| Experiment for Drug Resistance |
MTT assay; TUNEL assay; Lactate dehydrogenase assay | |||
| Mechanism Description | LncRNA ACART protects cardiomyocytes from apoptosis by activating PPAR- gama /Bcl-2 pathway. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
